DXC's second-quarter fiscal 2027 revenue was $3.0 billion, down 4.0% on an organic basis, while EBIT fell to $66 million, down 52.2%. Adjusted EBIT was $187 million, down 26.4%.
DXC · DXC Technology Co
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Price & Indicators
Up next
Latest documents
DXC Technology reported second-quarter fiscal 2027 total revenue of $3.03 billion, down 4.0% year-over-year, and non-GAAP diluted EPS of $0.67, down 20.2%. It acknowledged ongoing discussions regarding a possible sale of its insurance business. Full-year fiscal 2027 revenue is guided between $11.91 billion and $11.98 billion.
Metrics snapshot
Useful current figures from the complete screener profile.
Quarterly results
* Q4 derived as the full year minus Q1 to Q3.
AI Brief
Q4 FY26 earnings call · May 7, 2026TL;DR. DXC delivered Q4 adjusted EBIT margin and full-year free cash flow ahead of expectations, but Q4 organic revenue missed guidance by ~$75M (6.6% organic decline) on weaker project-based services. For FY27, DXC guided to a further 3–5% organic revenue decline with adjusted EBIT margin of 6–7% and FCF of ~$600M, all below FY26.
- + Q4 adjusted EBIT margin of 7.6% was above guidance and up 30 bps YoY
- + Reduced debt by $808M via cash payments over two years and net debt by $1.1B
- + FY26 share repurchases of $250M retired nearly 10% of outstanding shares
- − Q4 organic revenue missed guidance by ~$75M, declining 6.6% YoY
- − FY27 guidance implies further deterioration: 3–5% organic revenue decline and 6–7% adjusted EBIT margin
- − FY27 free cash flow guided to ~$600M, down from $713M in FY26
- − FY27 non-GAAP EPS guided to $2.40–$2.90, down from $3.23 in FY26
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Still-open targets the latest release did not restate under the same label.
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Cash conversion cycle | 14 | Three Months Ended June 30, 2026 filing | — |
| Days of purchases outstanding in accounts payable | -57 | Three Months Ended June 30, 2026 filing | — |
| Days of sales outstanding in accounts receivable | 71 | Three Months Ended June 30, 2026 filing | — |
| Non-GAAP income before income taxes non-GAAP | $138M | the three months ended June 30, 2026 filing | — |
GAAP → non-GAAP reconciliationGAAP Income before income taxes 241M
+26M RestructuringCosts
+87M Amortizationof AcquiredIntangibleAssets
-214M Gain onLitigation Award
-2M Gains on Dispositions
= Non-GAAP income before income taxes 138M
|
|||
| Organic revenue growth (CES segment) non-GAAP | 3% | first quarter of fiscal 2027 filing | — |
| Organic revenue growth (GIS segment) non-GAAP | 11.1% | first quarter of fiscal 2027 filing | — |
| Shares repurchased under our Share Repurchase Program | 6,704,651 | the first quarter of fiscal 2027 filing | — |
| Total profit for reportable segments | 172M | the three months ended June 30, 2026 filing | — |
| Adjusted EBIT non-GAAP | $150M | Q1 FY27 | — |
| Adjusted EBIT margin non-GAAP | 5% | Q1 FY27 | — |
| Bookings | 3B | Q1 FY27 | — |
| CES organic revenue growth non-GAAP | -3% | Three Months Ended June 30, 2026 | — |
| CES profit | $100M | Three Months Ended June 30, 2026 | — |
| CES profit margin | 8.1% | Three Months Ended June 30, 2026 | — |
| Free cash flow non-GAAP | $314M | Q1 FY27 | — |
| GIS organic revenue growth non-GAAP | -11.1% | Three Months Ended June 30, 2026 | — |
| GIS profit | $38M | Three Months Ended June 30, 2026 | — |
| GIS profit margin | 2.6% | Three Months Ended June 30, 2026 | — |
| Insurance organic revenue growth non-GAAP | 1.4% | Three Months Ended June 30, 2026 | — |
| Insurance profit | $34M | Three Months Ended June 30, 2026 | — |
| Insurance profit margin | 10.7% | Three Months Ended June 30, 2026 | — |
| Non-GAAP diluted earnings per share non-GAAP | $0.4 | Q1 FY27 | — |
| Segment profit margin (Consulting and Engineering Services) | 8.1% | Q1 FY27 | — |
| Segment profit margin (Global Infrastructure Services) | 2.6% | Q1 FY27 | — |
| Segment profit margin (Insurance Software & Services) | 10.7% | Q1 FY27 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Information Technology Services — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
DXC
this stock
DXC Technology Co
|
$2.22B | -2.7% | -1.8% | 20.7 | 13.0% |
|
IBM
International Business Machines Corp
|
$218.41B | -22.0% | +7.6% | 19.7 | 1.9% |
|
ACN
Accenture plc
|
$160.08B | -10.8% | +6.5% | 17.7 | 3.2% |
|
INFY
Infosys Ltd
|
$48.89B | -32.3% | — | — | 2.1% |
|
CTSH
Cognizant Technology Solutions Corp
|
$26.82B | -27.7% | +7.0% | 10.9 | 5.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every section- Filed
- Oct 30, 2026
- This year
- 17
DXC's second-quarter fiscal 2027 revenue was $3.0 billion, down 4.0% on an organic basis, while EBIT fell to $66 million, down 52.2%. Adjusted EBIT was $187 million, down 26.4%.
ViewPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| DXC | -6.9% | -2.5% | +53.8% | -4.8% | -2.7% |
| SPY | -2.3% | -4.8% | -2.9% | -3.1% | +7.4% |
| vs SPY | -4.5% | +2.2% | +56.8% | -1.7% | -10.1% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.